Study investigating advanced MRI scans to detect prostate cancer set to begin
the ONA take:
A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial. Tim Dudderidge, a consultant urological surgeon based at Southampton General Hospital, one of the ten centers involved in the trial, has cited the shortcomings of the traditional biopsy procedure; men with a raised PSA are typically advised to have a biopsy, but the biopsy may either miss existing cancer or lead to unnecessary surgery in the case of slow-growing cancer.
Traditional technique uses an ultrasound probe to guide a needle through the rectal walls and into the prostate for sample extraction. The procedure is normally performed on a patient under local anesthetic. The new procedure under review uses cutting-edge image technology, multi parametric (MP) MRI, to create very accurate scans to help determine location, size, and aggressiveness of the prostate cancer.
If successful, the advanced MRI technique could eliminate or reduce the need for invasive biopsies in some men, and provide greater detail at an earlier stage for men with conditions that warrant treatment. The trial involves ten centers spread across the country, with the goal to recruit 700 individuals with prostate cancer by October 2015 for participation.
A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|